Geneos Wealth Management’s ROBO Global Healthcare Technology and Innovation ETF HTEC Stock Holding History

Geneos Wealth Management’s Portfolio HTEC Stock Details HTEC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-500	Closed	-$14K	–	2273
2022 Q2	$14K	Hold	500	–	–	﹤0.01%	1834
2022 Q1	$18K	Hold	500	–	–	﹤0.01%	1851
2021 Q4	$21K	Hold	500	–	–	﹤0.01%	1859
2021 Q3	$22K	Hold	500	–	–	﹤0.01%	1878
2021 Q2	$23K	Sell	500 -850	-63%	-$38.6K	﹤0.01%	1845
2021 Q1	$62K	Sell	1,350 -200	-13%	-$9.3K	﹤0.01%	1517
2020 Q4	$67K	Buy	+1,550	New	+$60.6K	﹤0.01%	1317

Other funds holding HTEC

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SCM

SOL Capital Management Rockville, Maryland $206M AUM 17.87% 1-Year Est. Return

Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Geneos Wealth Management's HTEC Position: Q3 2022 in Review

Geneos Wealth Management sold out of ROBO Global Healthcare Technology and Innovation ETF (HTEC) in Q3 2022, closing a stake of 500 shares — an estimated $14K sold.

Geneos Wealth Management first reported a position in HTEC in Q4 2020 and held it in 7 quarters. The position peaked at $67K in Q4 2020. 33 funds tracked by Wall St. Rank hold HTEC as of Q3 2022.

Geneos Wealth Management reported no remaining ROBO Global Healthcare Technology and Innovation ETF position as of Q3 2022 after selling out during the quarter.
Geneos Wealth Management sold 500 ROBO Global Healthcare Technology and Innovation ETF shares in Q3 2022, an estimated $14K.
Geneos Wealth Management first reported a position in ROBO Global Healthcare Technology and Innovation ETF in Q4 2020 and held it in 7 quarters.
Geneos Wealth Management's ROBO Global Healthcare Technology and Innovation ETF position peaked at $67K in Q4 2020.
33 funds tracked by Wall St. Rank held ROBO Global Healthcare Technology and Innovation ETF as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.